Chris has over 35 years of healthcare experience, joining THINKMD as CEO in 2021.
He started his career with IBM as a field sales professional, before moving to IDX Systems Corporation, a healthcare technology company. IDX was acquired by GE Healthcare in 2006 and Chris worked as Senior Vice President and General Manager of GE Healthcare Americas Commercial Healthcare IT business, including the United States, Canada and Central and South America. Chris left GE in 2011 and went on to become CEO at Precyse. Under Chris’ leadership and growth, Precyse experienced significant growth in revenue and service offerings and was acquired by Pamplona Partners in 2016 to form nThrive, a healthcare revenue cycle and service company.
In 2017 Chris and a group of local investors acquired a local toxicology lab to formulate a healthcare company specifically designed to drive population health in the Substance Use Disorder (SUD) and Pain Management market. Chris led Aspenti as CEO, building a team that made significant strides in servicing the substance use patients in the New England area.
Chris brings his expertise to the THINKMD team, leading the company into its next phase of growth.